Skip to main content
Top
Published in: Journal of Inflammation 1/2013

Open Access 01-08-2013 | Poster presentation

A COPD-like model of viral exacerbation: synergistic effects with smoke and poly I:C

Authors: F Schlerman, J Kubera, M Fleming, K Nocka, C Williams

Published in: Journal of Inflammation | Special Issue 1/2013

Login to get access

Excerpt

Viral exacerbations in patients with COPD can accentuate disease severity by increasing lung inflammation and decreasing lung function. Using a synthetic analog of double stranded RNA (Poly I:C ) in combination with cigarette smoke, we have found synergistic increases in total lung inflammation as well as other tissue biomarkers compared to Poly I:C alone. Female C57 BL/6 mice were exposed to room air or the smoke of 3R4F Kentucky Reference cigarettes twice daily for two weeks. On days 0, 3 and 7 animals were dosed with intranasal PBS or 50 ug of Poly I:C. On day 11 we observed significant increases in total inflammation, absolute macrophages and absolute neutrophils in animals receiving smoke+Poly I:C compared to Poly I:C alone. There was also a trend showing increased absolute lymphocyte counts with increases observed in both CD4+ and CD8+ T cells in animals receiving Poly I:C alone or in combination with smoke. Gene expression from whole lungs showed synergistic increases in the TH17 cytokines, IL-21, IL-22 compared to Poly I:C alone. In addition, increases in the expression of elastin in lung tissue may indicate the beginning of tissue damage which could potentially lead to increased alveolar space with longer exposure to smoke. This model of viral exacerbation has robust, reproducible inflammation, with an inflammatory cell influx that resembles inflammation in human COPD and has the potential to identify novel protein and gene expression biomarkers. …
Metadata
Title
A COPD-like model of viral exacerbation: synergistic effects with smoke and poly I:C
Authors
F Schlerman
J Kubera
M Fleming
K Nocka
C Williams
Publication date
01-08-2013
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue Special Issue 1/2013
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-10-S1-P34

Other articles of this Special Issue 1/2013

Journal of Inflammation 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.